Search results
365 results found
Dr Susan MitchellOfori is responsible for delivering key communications of PHG Foundation projects and products. With a BA (Hons) in Media Production, Ofori will utilise and expand PHG Foundation's multimedia library.
Viruses for good – the case for phagesBlogThe case for the widespread use of phage therapies is gaining momentum, with several significant reports published in the last few months. Using phages to tackle antimicrobial resistence is showing particular promise. In the blog, we look at the what needs to happen next to make these viruses work for good
Reflections and key questions on data and AI for healthNewsThe regulation and governance of AI, data and digital health was the theme for this year’s WYNG-Hatton conference.
Biomarkers and their clinical utility in preventionBlogOur recommendations to PROPHET-EU call for a broader suite of evidence around biomarkers and their clinical utility in prevention
Future-proofing protection against pandemicsBlogAdvances in computational biology are opening new doors for vaccine development and the momentum to develop pan-spectrum vaccines for viral infections has never been greater.
Policy engagementWe work closely with a host of stakeholders – policy and decision makers, health professionals, regulators and researchers. Sometimes this includes direct engagement with politicians to inform them about relevant developments and convene or join discussions about our policy priorities.
The European Health Data Space Regulation has arrivedBlogThe European Health Data Space Regulation has arrived but will its mandatory sharing requirement be its tour de force or Achilles’ heel?
A much needed call to action – the launch of the Global Heat Health Resilience statementBlogThe consensus statement, initiated by the Physiological Society, calls on governments to recognise the challenge that rising temperatures are presenting to human health.
Regulating Advanced Therapy Medicinal Products in the UK after BrexitPolicy briefingAdvanced Therapy Medicinal Products offers new opportunities in treatment and intervention for diseases but it is not without challenges.
How do we close the diversity gap in genomics?BlogPHG policy analysts Tanya Brigden and Bhavya Krishnan bring perspectives from their respective fields to discuss how to close the diversity gap